Clinical Trials Logo
  1. Home
  2. Tendonitis
  3. NCT00426985

Efficacy and Safety of Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Shoulder, Elbow or Knee Tendonitis or Bursitis

Bursitis Clinical Trial

Official title:
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Phase III Study of the Efficacy, Tolerability and Safety of Ketoprofen Topical Patch, 20% (KTP) in the Treatment of Pain Associated With Tendonitis or Bursitis of the Shoulder, Elbow or Knee

Clinical Trial Summary

The purpose of this study is to evaluate the effect of a ketoprofen topical patch on the pain associated with tendonitis or bursitis of the shoulder, elbow or knee

Clinical Trial Description

This randomized, double-blind, placebo-controlled, parallel group study will be conducted in patients with tendonitis or bursitis of the shoulder, elbow or knee. Eligible patients will have tendonitis or bursitis or the shoulder, elbow or knee and will be randomized (1:1 ratio) to receive double-blind treatment with either the KTP or a matching placebo patch to be applied once daily for 21 days. Patients will return to the clinic for assessments on Day 3, Day 7, Day 14 and Day 21; a follow-up assessment will be conducted by telephone on Day 35. At each visit through Day 21, patients will rate their average pain intensity during daily activities and while at rest using the 11-point scale (range 0 to 10), and will rate their functional disability. Patients will also complete an electronic diary in which pain intensity and pain relief ratings will be recorded three times daily. The use of study treatment and rescue medication will be recorded in the diary each day. Ibuprofen will be provided as prn rescue medication. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00426985
Study type Interventional
Source Endo Pharmaceuticals
Contact
Status Terminated
Phase Phase 3
Start date January 2007
Completion date October 2008
View Details
See also
  Status Clinical Trial Phase
Completed NCT01205477 - Safety and Efficacy of Methylprednisolone Infiltration in Anserine Bursitis Treatment Phase 2
Terminated NCT01807962 - Local Injection Under US Control in GTPS. Phase 3
Completed NCT01050465 - MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use N/A
Completed NCT02841462 - Hydrothermal Ablation in Recurrent and Chronic Symptomatic Bursitis N/A
Withdrawn NCT00863889 - Steroid Injection for the Treatment of Greater Trochanteric Pain Syndrome Phase 4
Completed NCT00480675 - Randomized Study Comparing Fluoroscopically-Guided Versus Blinded Trochanteric Bursa Injections N/A
Withdrawn NCT00914836 - Comparison of 2 Doses of Corticosteroid Subacromial Injections for the Treatment of Painful Shoulder N/A
Completed NCT00352625 - Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Shoulder, Elbow or Knee Tendonitis or Bursitis Phase 3
Terminated NCT04931511 - Comparison Between Subacromial Ultrasound Guided and Systemic Steroid Injection for Frozen Shoulder Phase 4
Completed NCT01161615 - MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder Phase 3
Completed NCT00634608 - Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow N/A
Completed NCT01506154 - Safety & Efficacy Study of MRX-7EAT Patch in the Treatment of Pain of the Shoulder Phase 3
Completed NCT02221817 - Comparison of Ultrasound Guided Versus Blind Corticosteroid Injection for Trochanteric Bursitis N/A
Completed NCT02126878 - Comparison of Steroid Dosages on the Efficacy of Trochanteric Bursa Injection N/A